New discoveries by Cambridge scientists about a molecular waste-disposal process that ‘eats’ bacteria are influencing the clinical management of cystic fibrosis, and could be the basis of innovative new treatments to fight off bacteria.
A new generation of cancer therapeutics is on the horizon thanks to fresh light being shed on how genes are switched on and off.
The path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis.
Some remarkable organisms are able to withstand almost complete desiccation. How they survive is providing Cambridge researchers with new ideas for biostable therapeutics.
The first Asian and African human genomes have been deciphered using a technique originally invented by Professors Shankar Balasubramanian and David Klenerman at the University of Cambridge's Department of Chemistry and developed by the spin-out Solexa.
© 2025 University of Cambridge